Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1999
03/23/1999US5886151 An isolated and purified dna molecule encoding candida albicans protein with integrin-like motifs; for use in vaccines
03/23/1999US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
03/23/1999US5886149 P53 response genes
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5886142 Radiolabeled thrombus imaging agents
03/23/1999US5886141 Smooth muscle mitogen peptides and DNA coding therefor
03/23/1999US5886026 Anti-angiogenic compositions and methods of use
03/23/1999US5885970 Antisense oligonucleotides against human protein kinase C
03/23/1999US5885965 Synthetic human salivary proteins as fungicides or bactericides, treating infections
03/23/1999US5885964 Administering to the patient suffering from osteoporosis an effective amount of an agent comprising kininogen or kininogen peptide to prevent bone resorption
03/23/1999US5885963 Administering to said pests, or the environment of said pests, a pesticidally effective amount of a bacillus thuringiensis delta-endotoxin from the bacillus thuringiensis isolate ps123d1
03/23/1999US5885962 Stem cell factor analog compositions and method
03/23/1999US5885961 Methods of using epithelins to modulate cell proliferation
03/23/1999US5885956 Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand
03/23/1999US5885831 A protein encoded by drosophila timeless gene; a kit useful for diagnosis and treatment of disorders related to sleep wake cycle
03/23/1999US5885829 Growing viable oral tissue cells on a synthetic matrix in vitro under conditions effective and for a period of time sufficient to allow proliferation of viable oral tissue cells
03/23/1999US5885828 SecA gene of mycobacterium tuberculosis and related methods and compositions
03/23/1999US5885824 Recombinant genomic clone encoding the histamine H2 receptor, methods for production thereof, and protein produced therefrom
03/23/1999US5885811 Leader sequence inducing a post-translational modification of polypeptides in bacteria gene therefor and subtilin variant of enhanced stability and activity
03/23/1999US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting
03/23/1999US5885805 gbpA
03/23/1999US5885804 Genetic engineered polynucleotides and encoded polypeptides of the atp-binding protein family, treating meningitis, infection of cerebrospinal fluid
03/23/1999US5885802 High methionine derivatives of α-hordothionin
03/23/1999US5885801 Protein enriched in threonine residues which can be expressed in plants used for foods or animal feeds
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885799 Hepatitis C virus protease
03/23/1999US5885798 Isolated polynucleotide sequence encoding the polypeptide comprising the given amino acid sequence
03/23/1999US5885797 Polynucleotide sequences encoding proteins involved in myogenesis
03/23/1999US5885796 CTLA4 receptor and uses thereof
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885794 Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily
03/23/1999US5885793 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
03/23/1999US5885785 DNA encoding a human serotonin (5-HT2) receptor and uses thereof
03/23/1999US5885783 Autoimmune inner ear disease antigen and diagnostic assay
03/23/1999US5885782 Microbiocide oligopeptide mixture comprising at least two amino acid sequences; fungicides for treating plant or human
03/23/1999US5885779 Repressed trans-activator system for characterization of protein-protein interactions
03/23/1999US5885776 Glaucoma compositions and therapeutic and diagnositic uses therefor
03/23/1999US5885772 Method for the detection of anencephaly
03/23/1999US5885771 Measuring an antibody relating to hepatitis c virus; suppression of cross or non-specific reactions; determination of genotype-i and -ii; monitoring interferon therapy; amino acid sequences
03/23/1999US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies
03/23/1999US5885589 Pasteurella vaccine
03/23/1999US5885587 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens
03/23/1999US5885586 Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
03/23/1999US5885585 Virus derived from 65th passage of cpv-39; vaccines against canine parvovirus or feline panleukopenia virus
03/23/1999US5885580 A fusion protein obtained by inserting a foreign antigen peptide into the molecular surface of an antigen derived from mycobacteria, has significant increased antigenicity and immunogenicity
03/23/1999US5885579 CTLA4 receptor and uses thereof
03/23/1999US5885578 Immunizing a mammal with immunogen comprising two or more hiv proteins, free of outer envelope protein, which stimulates production of anti-hiv antibodies and recovering the produced anti-hiv antibodies
03/23/1999US5885577 Possess binding specificities that are similar to the binding specificities of the antibodies or receptors; may be used in place of antibodies in many assays or therapeutic applications
03/23/1999US5885575 Diagnosis and therapy of tumour metastases
03/23/1999US5885574 Antibodies which activate an erythropoietin receptor
03/23/1999US5885571 Bacillus thuringiensis strains and their insecticidal proteins
03/23/1999US5885569 Biological insect control agent
03/23/1999US5885568 Coccidiosis poultry vaccine
03/23/1999US5885567 Treatment of infection in fowl by oral administration of avian interferon proteins
03/23/1999CA2127462C Treatment for asthma
03/23/1999CA2083168C Adsorbent for cellular fibronectin and a method for fractional purification of fibronectin
03/23/1999CA2077405C Virus resistant plants and method therefore
03/23/1999CA1340461C Alveolar surfactant proteins
03/23/1999CA1340460C Electrochemiluminescent rhenium moieties and methods for their use
03/23/1999CA1340455C Human preproinsulin-like growth factor i
03/23/1999CA1340454C Diuretic peptide and gene coding same
03/23/1999CA1340453C Human atrial natriuretic peptide and gene coding for same
03/22/1999CA2244239A1 Novel era
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/19/1999CA2244880A1 Synuclein-based assay and novel synuclein protein
03/19/1999CA2216057A1 Polymorphic cag repeat-containing gene, diagnosis of psychiatric diseases and therapeutic uses thereof
03/19/1999CA2211003A1 Human tumor necrosis factor receptor
03/18/1999WO1999013338A1 dsRNA/dsRNA-BINDING PROTEIN METHODS AND COMPOSITIONS
03/18/1999WO1999013111A1 Reagents and methods useful for detecting diseases of the prostate
03/18/1999WO1999013097A1 Stabilization of helicobacter urease
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013092A1 Enhancement of mucosal antibody responses by interleukin-6
03/18/1999WO1999013090A1 Regulation of protein secretion
03/18/1999WO1999013084A1 Group a streptococcal vaccines
03/18/1999WO1999013083A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/18/1999WO1999013082A1 Cxc chemokine
03/18/1999WO1999013081A1 EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM)
03/18/1999WO1999013080A1 Beta-defensins
03/18/1999WO1999013079A1 Rin2, a novel inhibitor of ras-mediated signaling
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013077A2 Inducible methods for repressing gene function
03/18/1999WO1999013076A1 Mpl ligand analogs
03/18/1999WO1999013075A2 Human genes regulated by human cytomegalovirus and interferon
03/18/1999WO1999013074A1 Protein having activity of activiting nerve cell functions
03/18/1999WO1999013073A2 Viral vector system capable of expressing an apoptosis-associated gene
03/18/1999WO1999013072A1 Transporter genes
03/18/1999WO1999013071A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999WO1999013069A1 Repressed trans-activator system for characterization of protein-protein interactions
03/18/1999WO1999013068A2 Transgenic animal model of prostate cancer
03/18/1999WO1999013066A1 Secreted proteins and polynucleotides encoding them
03/18/1999WO1999013065A1 Novel primer and use thereof
03/18/1999WO1999013061A1 Plus end-directed microtubule motor required for chromosome congression
03/18/1999WO1999013056A1 IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs)
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999013053A1 Genetically modified tumor-targeted bacteria with reduced virulence
03/18/1999WO1999012971A2 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
03/18/1999WO1999012970A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999WO1999012969A1 Treatment of obesity
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012967A1 Retro-inverso neurotrophic and analgesic peptides